Hematologist at KCMH, Bangkok🇹🇭 Thrombosis and hemostasis. Past member of ISTH early career committee. Social media AE @jthjournal
Joined May 2017
- Tweets 422
- Following 532
- Followers 351
- Likes 859
45 Photos and videos
Thita Joy Chiasakul retweeted
23 Jun 2025
Had a great time at the Peer Mentoring: Early Career Professionals in the Spotlight session at #ISTH2025 🎤💡
Moderated by @joythitac
So cool to hear everyone’s journey from abstract to presentation—lots of insights, laughs, and inspiration 💬✨
@ChoHanChiang29
#HemeTwitter #EarlyCareer #MedicalLife #ISTH #Mentorship #AbstractTips @isth @IsthPresident
1
8
789
Thita Joy Chiasakul retweeted
30 Nov 2024
📍New editorial from the @isth Early Career Committee highlighting the importance of interdisciplinary collaboration and its opportunities within the thrombosis and hemostasis field. 🔖
#ISTHEarlyCareer
@SarahSewar @kohli_shrey @beckyzon @Aaron_Iding @NicolaPotereMD
@Plateletpaul @gauer_s @joythitac @PoolePAR_ty @renee_eslick @zara_sayar
30 Nov 2024
📣📣The ECC's latest editorial is out!
Hope you enjoy reading it as much as we enjoyed writing it
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche -Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538…
9
16
3,078
Thita Joy Chiasakul retweeted
16 Nov 2024
Our recent research in collaboration with Roland Jäger and @cj_binder indicates that clonal haemopoiesis (CHIP) is a novel risk factor for (unprovoked) venous thromboembolism (VTE). Previously, CHIP has been identified as risk factor for atherosclerotic vascular disease.
16 Nov 2024
Association of clonal haematopoiesis with recurrent venous thromboembolism: A case–control study @Cihan_Ay_MD
buff.ly/48HGAba
1
14
45
4,592
Thita Joy Chiasakul retweeted
14 Nov 2024
Hi everyone! If you are looking for more places to follow JTH, you can find us where the sky is blue: jthjournal.bsky.social
*NOTE: We will still continue posting content here for now.
1
6
1,268
Thita Joy Chiasakul retweeted
7 Nov 2024
Nice to see that the message getting through that the ONLY indication for IVC filter is contraindication to anticoagulation and acute venous thrombosis (DVT and/or PE) in the last 14 days. BUT message that prescriber must follow-up until IVC filter is out clearly still needs work
6 Nov 2024
Inferior vena cava filter (IVCF) insertion declined from 2013 to 2021, yet retrieval rates remained low and nonretrieved IVCFs were associated with an increased risk of long-term complications, such as DVT and caval thrombosis. ja.ma/3YUAaSM
4
24
52
9,613
4 Nov 2024
Helpful article to refer to in your clinic 🤓
3 Nov 2024
"I'm seeing my dentist for a root canal next week" said your patient who is taking anticoagulants 🦷🩸
We've got you! This article reviews the latest guidance on periprocedural antithrombotic management in dental care and offers practical, evidence-based approaches. #Antithrombotics #DentalCare #PatientSafety
✍️ @bbikdeli
Read it now: jthjournal.org/article/S1538…
5
7
1,359
Thita Joy Chiasakul retweeted
2 Nov 2024
The PDF of the guidance on the management of individuals with #hemophilia who have cleared the hepatitis C virus in now available in the @JTHjournal. You can not forget about the impact of hepatitis on the liver when you have cleared it. This figure and the text in the paper are the most relevant. tinyurl.com/yz7s875m
1
9
17
2,335
Thita Joy Chiasakul retweeted
28 Oct 2024
The Thai Red Cross Society is inviting healthy blood donors to celebrate Halloween this year by donating blood in Halloween costume this Friday.
Read more: world.thaipbs.or.th/detail/t…
#ThaiPBSWorld #ThailandNews #blooddonation #RedCross #Halloween
6
9
1,263
28 Oct 2024
Have you checked out the latest issue of @JTHjournal ?
28 Oct 2024
Our #November issue is now available
In this issue:
▶️ #Reviews: extravascular vesicles, AAV vector, treatment of vascular malformation, ovarian vein thrombosis
▶️#Thrombosis: DOACs in very elderly, predicting CV risk in cancer, post-PE care, risk of PTS, registry of AT def, impaired fibrinolysis in MPN & ITP
▶️ #Hemostasis: VitK deficiency, vWD, gene therapy for hemophilia B, cleavage of prothrombin without membranes
▶️ #Platelet: Unconventional secretion system in megakaryocytes, GPIb-independent platelet aggregation
Read here: jthjournal.org/current
2
16
1,767
Thita Joy Chiasakul retweeted
25 Oct 2024
How do you go about planning #ClassicalHematology sessions to attend at #ASH24? Would love for attendings/fellows to share how they approach it. I’ll keep adding replies to this tweet based on what I learn and plan to attend!
@ASH_hematology @HTRStoday @HTRSFellows
1
2
11
904
23 Oct 2024
Read this!
22 Oct 2024
🤰VTE is a leading cause of morbidity and mortality in pregnancy.
This new JTH in Clinic Review covers evidences on VTE diagnosis and management, thrombophilia testing, and thromboprophylaxis in pregnancy. A must-read for clinicians!
✍️ @LaurenMerzMD @fniainle
Read it here:
jthjournal.org/article/S1538…
6
352
23 Oct 2024
Thank you @isth @GBarnesMD for an opportunity to be featured on this podcast. A totally new experience for me! 😅
🚨New Pulse Podcast episode alert: Join us to hear about @joythitac's journey through the field of thrombosis & hemostasis as an early-career professional with host @GBarnesMD!
Discover how Joy navigated mentorship and unlocked new opportunities along the way, plus hear fun facts about life as a Bangkok native 🌏 Listen here: pod.link/1555328920
1
4
22
1,818
Thita Joy Chiasakul retweeted
11 Oct 2024
Scientist by day, Musician by night.
Highly recommended listening to this #podcast hosted by @GBarnesMD with @DanielSteinerMD on his research in #VTE & experiences. Great example of the valuable contribution of young researcher to #thrombosis. #WTDay24
jthjournal.org/article/S1538…
🎙️New podcast episode just dropped! Our latest episode features @GBarnesMD & Daniel Steiner, an early career researcher, sharing his insights into the psychological consequences of VTE, as highlighted in his @JTHjournal paper!
Tune in: pod.link/1555328920
11
21
1,788
Thita Joy Chiasakul retweeted
9 Oct 2024
We are ready for the Thrombosis Day tomorrow at Ramathibodi Hospital. Please join the interesting activity from 0830 to 1100 AM.
#WTday24 @IPTNetwork @thrombosisday
3
11
672
Thita Joy Chiasakul retweeted
7 Oct 2024
Join us in welcoming several 2024 Associate Editors! Thank you for joining us in our mission to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. Click here for more info bit.ly/3BLlkVm
1
8
31
2,932
📣 Calling all early career ISTH members: Curious about career options beyond academia? 🧑🔬👩🔬 Join our next webinar on October 22 to explore exciting research career paths available to you!
🔗 Register here: us02web.zoom.us/webinar/regi… #ISTH #ResearchCareers
5
11
1,084
Thita Joy Chiasakul retweeted
25 Sep 2024
To use or not to use reversal agents for DOACs? 🤔
Not all DOAC-associated bleeds require reversal.
This table summarizes guidance from @isth SSC on this issue
✍️@JerroldLevy @LanaCastellucci @connors_md @DebSiegal
Read this important paper at jthjournal.org/article/S1538…
1
51
93
10,371
Thita Joy Chiasakul retweeted
6 Sep 2024
Terrific 2 days of meetings to plan sessions for the 2025 @isth Congress. Name your favorite #hemostasis or #thrombosis topic. It will be there. So should you! #science 🩸
3
7
82
5,073
6 Sep 2024
Truly honored to join the team @JTHjournal and excited for what’s ahead. A heartfelt thank you to @DianvanderwalDr for her outstanding service — such big shoes for me to fill! T&H community, please feel free to reach out to share any suggestions or ideas! @isth #ISTHEarlyCareer
6 Sep 2024
Please join us in giving a HUGE thank you to @DianvanderwalDr for serving as a JTH social media editor for over five years🎊🎇, we will surely miss you Dianne!! We are also thrilled to give a warm welcome to @joythitac as our new social media editor for X.
9
4
46
2,997
Thita Joy Chiasakul retweeted
28 Aug 2024
🧵Thread on the ANNEXA trials for reversing DOAC-related bleeds 🩸
As #DOAC (FXa inhibitors) have increasingly replaced VKAs, let’s discuss the development and study of their reversal agent #andexanet alfa, a recombinant inactive FXa that sequesters FXa inhibitor molecules
1/
3
23
63
21,837